Zematop New Zealand - English - Medsafe (Medicines Safety Authority)

zematop

douglas pharmaceuticals limited - tacrolimus monohydrate 1.022 mg/g equivalent to tacrolimus 1.0 mg/g;   - topical ointment - 1 mg/g - active: tacrolimus monohydrate 1.022 mg/g equivalent to tacrolimus 1.0 mg/g   excipient: hard paraffin liquid paraffin propylene carbonate white beeswax white soft paraffin - zematop 0.1% ointment is indicated in adults and adolescents (16 years of age and above). flare treatment adults and adolescents (16 years of age and above) treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. maintenance treatment treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).